Orsense - Non-Invasive Technologues

Please choose your location:

   
Orsense - non-invasive technologies

Diabetes & Blood Glucose

Diabetes is a chronic disease in which insulin, a hormone that regulates blood sugar is either not produced by the pancreas (Type I diabetes), or not efficiently utilized by the body (Type II and gestational diabetes). Hyperglycemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's systems, especially the nerves and blood vessels.

Currently there are over 350 million people worldwide with diabetes, with over 3.5 million deaths per year from consequences of high blood sugar. Among the many complications of this disease are:

  • Increased risk of heart disease and stroke. 50% of people with diabetes die of cardiovascular disease.
  • Increased risk for foot ulcers and eventual limb amputation.
  • Increased risk for diabetic retinopathy, an important cause of blindness. After 15 years of diabetes, approximately 2% of people become blind, and about 10% develop severe visual impairment.
  • Diabetes is among the leading causes of kidney failure. 10-20% of people with diabetes die of kidney failure.
  • Diabetic neuropathy affects up to 50% of people with diabetes.
  • The overall risk of dying among people with diabetes is at least double the risk of their peers without diabetes.
  • People with diabetes monitor blood glucose levels between 3-12 times per day. Current blood glucose screening solutions are invasive, painful and predispose to infections. Therefore, more efficient methods of screening, diagnosing and monitoring diabetes can improve the lives of diabetics and prevent complications.
  • People with diabetes often suffer from undiagnosed and untreated anemia, leading to fatigue and other possible complications.

The OrSense solution

OrSense's next generation products target non-invasive monitoring of blood glucose in the hospital and for home use. The CE approved glucose monitor was tested on over 450 diabetic subjects. Results indicate performance similar to those of invasive glucose sensors on the market today. The OrSense Glasswing non-invasive hemoglobin monitor is also an essential partner for improving the quality of life of diabetics, by enabling routine, painless and reliable assessment of anemia.